HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 26, Nos. 07 & 08, July & August 2022 – Engineering a Sustainable Future       » Improving Crop Yield With Leaf Angles       » Combatting Tumours at the Gut With Novel Oral Vaccine Made by Bacteria Robot       » New Carbon Capture System With Record-Breaking Efficiency to Revolutionise Direct Air Capture       » Simulating the Synergistic Interactions of Neurons and Synapses in Computing Devices       » Understanding Gene Functions: From Algae to Plants       » Colour-Modified Mice Tissues Allow for Higher-Resolution Imaging      
Vol 21, No. 08, August 2017   |   Issue PDF view/purchase
EDITOR'S LETTER
We call this August issue “Eyes – the Window to your Soul”. The team behind APBN is honoured to invite Associate Professor Ian Yeo Yew San from Singapore National Eye Centre as our guest editor. In his article, he talks about the controlled environment of a clinical trial can never be replicated in a real life clinical setting due to limited resources. Clinical trials are cornerstones of evidence-based medicine (EBM) but they are only one of the components in the complex landscape of healthcare practice. You can read more on “Clinical Trials in our Real World”.

Age Related Macula Degeneration (AMD) is a common eye disease among people aged 50 and above. AMD, as suggested by its name, occurs due to the damage of macula, the most sensitive part of retina in our eyes. This eye condition can be classified into early, intermediate and advanced stage and is the leading cause for gradual vision loss in many older people. An article in Features, written by Dr Anna Tan, discusses the current and emerging diagnostic (imaging) and therapeutic developments in AMD. The significant developments in imaging for this disease include optical coherence tomography (OCT), fundus autofluorescence (FAF) and adaptive optics. Also check out the articles from other clinicians and scientists to learn more about the international collaborations done to address healthcare issues due to aging.

In Spotlights, APBN interviews Dr Allen Lai, the Senior Vice President of ACT Genomics, on how genetic testing can help in figuring customised and more effective treatment for cancer patients. We also feature several distinguished scientists from Commonwealth countries about agricultural biotechnology, stem cell research and burdens of malnutrition, respectively. If you are interested in robotics, it would be good to know that robots might be potentially used in eye surgery to help overcome challenges in ophthalmology in coming years.

Hope you enjoy reading APBN and take initiatives to protect and care for your eyes.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at [email protected]

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

FORTHCOMING ISSUE  
MGI Makes Possible New Advances in Agrigenomics Research and Molecular Breeding
NEWS CRUNCH  
news Medtec China 2022 Gathers Medtech Leading Enterprises, Optimising Medical Equipment Supply Chain by Creating Online-Offline Promotion Platforms
news Medtec China 2022 Is Now Open for Visitor Registration, Helping Medical Device Manufacturers in Medtech Sourcing and Supply Chain Stabilisation
news Inaugural Asia Summit on Global Health highlights Hong Kong's advantages
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy